Welcome to the Minnesota Medical Assistance Portal
Minnesota Medical Assistance Fee-For-Service Pharmacy Program
Changes to Coverage for Salix Pharmaceuticals Drugs. Effective 10/01/2025
Effective October 1, 2025, Salix Pharmaceuticals, Inc. will no longer participate in the federal Medicaid Drug Rebate Program. As a result, Medical Assistance (MA) will no longer cover Salix products under the Fee-for-Service Program. This includes commonly prescribed medications such as:
- Xifaxan®
- Relistor®
- Trulance®
Under federal and state law, MA can only cover drugs that are eligible for federal funding through the rebate program. While manufacturer participation is voluntary, opting out means their products cannot be reimbursed by MA. Please note that other manufacturers have also chosen to leave the program effective October 1, 2025.
What You Can Do:
Prescribers: Consider alternative medications that remain covered under MA.
Patients: Contact your healthcare provider to discuss treatment options.
Pharmacies: Adjust inventory and billing practices to avoid claim denials.
For a complete list of affected manufacturers, visit the Drug Manufacturer Contacts webpage on the U.S. Centers for Medicare & Medicaid website.
Announcements
Changes to Coverage for Salix Pharmaceuticals Drugs. Effective 10/01/2025
Effective October 1, 2025, Salix Pharmaceuticals, Inc. will no longer participate in the federal Medicaid Drug Rebate Program. As a result, Medical Assistance (MA) will no longer cover Salix products under the Fee-for-Service Program. This includes commonly prescribed medications such as:
- Xifaxan®
- Relistor®
- Trulance®
Under federal and state law, MA can only cover drugs that are eligible for federal funding through the rebate program. While manufacturer participation is voluntary, opting out means their products cannot be reimbursed by MA. Please note that other manufacturers have also chosen to leave the program effective October 1, 2025.
What You Can Do:
Prescribers: Consider alternative medications that remain covered under MA.
Patients: Contact your healthcare provider to discuss treatment options.
Pharmacies: Adjust inventory and billing practices to avoid claim denials.
For a complete list of affected manufacturers, visit the Drug Manufacturer Contacts webpage on the U.S. Centers for Medicare & Medicaid website.
Provider Manual Available Now
The Minnesota Health Care Program Pharmacy Modernization Module Provider Manual is now available.
Announcements
Provider Manual Available Now
The Minnesota Health Care Program Pharmacy Modernization Module Provider Manual is now available.